Athanor Capital, LP Kura Oncology, Inc. Transaction History

Athanor Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$24.75 - $39.14 $403,152 - $637,551	-16,289 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$29.0 - $41.62 $119,741 - $171,848	-4,129 Reduced 20.22%	16,289 $532,000
Q3 2020 Nov 16, 2020	SELL	$16.3 - $30.64 $128,688 - $241,902	-7,895 Reduced 27.88%	20,418 $626,000
Q2 2020 Aug 13, 2020	BUY	$7.95 - $18.81 $225,088 - $532,567	28,313 New	28,313 $462,000
Q1 2020 May 14, 2020	SELL	$6.45 - $14.04 $132,915 - $289,322	-20,607 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$12.97 - $15.94 $112,748 - $138,566	-8,693 Reduced 29.67%	20,607 $283,000
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $137,175 - $194,091	9,300 Added 46.5%	29,300 $444,000
Q2 2019 Aug 13, 2019	BUY	$14.71 - $19.79 $294,200 - $395,800	20,000 New	20,000 $394,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $490M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.